FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama
An FDA advisory committee has unanimously recommended the approval of Moderna's mRNA influenza vaccine for older adults.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A federal vaccine panel voted unanimously to recommend the authorization of Moderna’s mRNA-based flu vaccine. This decision marks the first time such an advisory committee has recommended a vaccine since 2023. The shot is intended for use in older adult populations.
Coverage from CIDRAP, NPR, Stat News, FirstWord Pharma, WRAL, NBC News, and Ars Technica emphasizes the unanimous nature of the vote. Reports also note that the approval process followed a period of agency drama and controversy surrounding the vaccine. Next steps involve the formal FDA regulatory process following this panel endorsement.
Coverage does not yet specify a final timeline for the vaccine's availability.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 134d ago.
Quick answers
Who is the vaccine for?
According to NBC News, the vaccine is intended for older adults.
What technology does the vaccine use?
The vaccine utilizes mRNA technology, described by reporting as first-of-its-kind for a flu shot.
Was the committee vote divided?
No, multiple outlets including Ars Technica and NPR report the vote was unanimous.
Coverage (7)
- Moderna’s mRNA flu vaccine gets thumbs up from federal vaccine panel CIDRAP · 136d ago
- Key FDA committee unanimously recommends its first vaccine since 2023 NPR · 136d ago
- FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy statnews.com · 136d ago
- FDA panel strongly backs Moderna's mRNA flu vaccine FirstWord Pharma · 136d ago
- FDA panel considers a first-of-its-kind flu vaccine using mRNA technology WRAL · 136d ago
- FDA panel recommends Moderna’s mRNA flu shot for older adults NBC News · 136d ago
- FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama Ars Technica · 136d ago
Topics
Related trends
Weekly US Influenza Surveillance Report: Key Updates for Week 42, ending October 24, 2026 | FluView
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
FDA plans to update infant formula nutrition requirements for first time in nearly 30 years
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Nearly 50 people have died across the US in recent days from flu as cases spike nationwide
A surge in flu cases has claimed nearly 50 lives nationwide, with Connecticut reporting six deaths and health officials urging urgent vaccination.
Child dies of flu-related illness in San Bernardino County
San Bernardino County reports its first pediatric flu-related death of 2026, marking a critical new development in public health.
FDA again bypasses advisers to remove black-box warnings from menopause treatments
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA warns cinnamon could be contaminated just ahead of holiday baking season
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.